Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. Read more
First Quarter 2024 Financial Results
Press Releases
Presentations
Events
May 22, 2024 at 9:00 AM EDT
May 7, 2024 at 8:00 AM EDT